Monograph

A08AB01 - Orlistat

Not porphyrinogenic

Rationale

Insignificant absorption.

Chemical description

Inhibitor of gastrointestinal lipase used in attempts at weight reduction.Given perorally in a dose of 360 mg/d .Metabolized in the gastrointestinal wall, producing two metabolites. Only insignificant absorbtion, plasma concentration < 10 ng/mL.

IPNet drug reports

Uneventful use reported in 2 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes A08A / A08AB or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Alli · Alli 27 mg, kauwtabletten · Alli 60 mg, harde capsules · Orlistat · Orlistat Sandoz 120 mg, harde capsules · Xenical · Xenical, capsules 120 mg

Belgium

Alli · Alli 60 mg gél. · Orlistat · Orlistat Sandoz 120 mg gél. · Orlistat Sandoz 60 mg gél. · Orlistat Teva 120 mg gél. · Orlistat Teva 60 mg gél. · Xenical · Xenical 120 mg gél.

United Kingdom

Alli · Alli 27mg chewable tablets · Alli 60mg capsules · Beacita · Beacita 120mg capsules · Orlistat · Orlistat 120mg capsules · Orlos · Orlos 60mg capsules · Xenical · Xenical 120mg capsules

Denmark